The present study aims to explore the influence of genetic polymorphisms of CYP1A1*2C and CYP2D6*4 on the susceptibility of patients with Ph-ve to CML, in Sudan. The gene discussed is CYP2D6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.